Sunday, November 22, 2020 4:08:57 PM
My one criticism against NP is that he, like most newbie CEOs with a deep technical background, believed the product would speak for itself. Therefore, all in the name of “transparency” they attempted to provide numerous “specs” and “details” instead of a prepared, rehearsed, and clear message. They also fail to realize when to say nothing at all, because that skillset is less developed. More importantly, they place overwhelming trust in the referees (e.g. government agencies) being fair and neutral because within an organization that is expected to crank out the best product.
I’ve worked for CEOs like above, trying to be like Gates, Jobs, or Musk, and they all make similar mistakes. That said, this is the boat we’re in, and so what are the alternatives for the next 3 months?
If we take the conspiracies off the table, it is quite clear that the FDA favors strategies that attack viruses head on and will reduce viral load, and that is not our (currently recognized) MO. Even if FDA officials understand our MO, telling the general public that something directly attacks the virus is likely to gain more acceptance and use among the public (and general practitioners) rather than try to explain what an immunomodulator is.
What we want the FDA or any other health agency to be able to say to the public is that “Vyrologix will prevent you from dying from Covid or any of our numerous potential indications!” This also why we shouldn’t do anything to jeopardize this message, including unblinding data and taking a penalty, particularly given that we are not cherry-picking participants and the SOC is improving.
Advocates for unblinding the data are also believing that the product will just speak for itself and ignoring all the social dynamics of governments telling the public to trust a small, relatively unknown biotech company.
Don’t provide reasons for governments to say no, whether technical, political, or otherwise! Comply with all rules and recommendations until you have built sufficient leverage before trying to circumvent any part of the process!
All IMO
Recent CYDY News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:55 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM